Zobrazeno 1 - 10
of 24
pro vyhledávání: '"E. I. Shramova"'
Autor:
O. V. Shlepova, M. A. Shulepko, V. O. Shipunova, M. L. Bychkov, I. D. Kukushkin, I. A. Chulina, V. N. Azev, E. I. Shramova, V. A. Kazakov, A. M. Ismailova, Y. A. Palikova, V. A. Palikov, E. A. Kalabina, E. A. Shaykhutdinova, G. A. Slashcheva, E. A. Tukhovskaya, I. A. Dyachenko, A. N. Murashev, S. M. Deyev, M. P. Kirpichnikov, Z. O. Shenkarev, E. N. Lyukmanova
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
α7-Type nicotinic acetylcholine receptor (α7-nAChR) promotes the growth and metastasis of solid tumors. Secreted Ly6/uPAR-Related Protein 1 (SLURP-1) is a specific negative modulator of α7-nAChR produced by epithelial cells. Here, we investigated
Externí odkaz:
https://doaj.org/article/68ca419785d04cd79f6b4a41671b974e
Autor:
M V, Novoselova, E I, Shramova, O V, Sergeeva, E Y, Shcherbinina, S V, Perevoschikov, P, Melnikov, O Yu, Griaznova, I S, Sergeev, E V, Konovalova, A A, Schulga, G M, Proshkina, T S, Zatsepin, S M, Deyev, D A, Gorin
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 47:102612
Nanomedicine has revolutionized the available treatment options during the last decade, but poor selectivity of targeted drug delivery and release is still poses a challenge. In this study, doxorubicin (DOX) and magnetite nanoparticles were encapsula
Autor:
E. I. Shramova, M. V. Shilova, G. M. Proshkina, Victoria O. Shipunova, Alexey A. Schulga, S. M. Deyev
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:1156-1161
In this work for the first time we demonstrate the possibility of ribonuclease barnase delivery to HER2-positive human cancer cells in a liposomal form. The principle of loading liposomes with ribonuclease is based on the electrostatic interaction of
Publikováno v:
Acta Naturae
Today, it has become apparent that innovative treatment methods, including those involving simultaneous diagnosis and therapy, are particularly in demand in modern cancer medicine. The development of nanomedicine offers new ways of increasing the the
Autor:
Georgij B Telegin, E. I. Shramova, N.A. Zolotova, G. M. Proshkina, D.S. Dzhalilova, M. V. Shilova, Sergey M. Deyev, Anastasiya V. Ryabova
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 340
For precise ligation of a targeting and cytotoxic moiety, the use of Barnase-Barstar pair as a molecular glue is proposed for the first time. Targeting was mediated through the use of a scaffold protein DARPin_9–29 specific for the human epidermal
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 4975, p 4975 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 4975, p 4975 (2021)
Cancer cells frequently overexpress specific surface receptors providing tumor growth and survival which can be used for precise therapy. Targeting cancer cell receptors with protein toxins is an attractive approach widely used in contemporary experi
Publikováno v:
Russian Journal of Bioorganic Chemistry. 44:755-758
Photodynamic therapy (PDT) is a clinically approved, minimally invasive method for tumor destruction in the presence of a photosensitizer (PS), oxygen, and a light source. The main obstacle for the PDT treatment of deep tumors is the problem of the e
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 188:107-115
Photodynamic therapy (PDT) is a clinical, minimally invasive method for destroying cancer cells in the presence of a photosensitizer, oxygen, and a light source. The main obstacle for the PDT treatment of deep tumors is a strong reduction of the exci
Autor:
Andrei V. Kabashin, G. M. Proshkina, Sergey M. Deyev, Victoria O. Shipunova, Alexey A. Schulga, E. I. Shramova, Ivan V. Zelepukin, Paras N. Prasad, Elena N. Komedchikova, Georgij B Telegin, Polina A. Kotelnikova, Hilliard L. Kutscher
Publikováno v:
ACS Nano
ACS Nano, American Chemical Society, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, American Chemical Society, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
When combined with immunotherapy, image-guided targeted delivery of chemotherapeutic agents is a promising direction for combination cancer theranostics, but this approach has so far produced only limited success due to a lack of molecular targets on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddce00ba8f18cf0d1a91f40794342a49
https://hal.archives-ouvertes.fr/hal-03097623
https://hal.archives-ouvertes.fr/hal-03097623
Publikováno v:
Russian Journal of Bioorganic Chemistry. 44:279-288
ErbB2/HER2 is a tyrosine kinase receptor belonging to the family of epidermal growth factor receptors (EGFRs); it is overexpressed in 25–30% of human breast cancer cases and has a number of structural and functional differences from other receptors